Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 52, Pages 14970-14975
Publisher
Proceedings of the National Academy of Sciences
Online
2016-12-14
DOI
10.1073/pnas.1609375114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
- (2016) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- SAbPred: a structure-based antibody prediction server
- (2016) James Dunbar et al. NUCLEIC ACIDS RESEARCH
- Direct production of functional matrix metalloproteinase-14 without refolding or activation and its application for in vitro inhibition assays
- (2015) Dong Hyun Nam et al. BIOTECHNOLOGY AND BIOENGINEERING
- Rational Design of Antibody Protease Inhibitors
- (2015) Tao Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species
- (2014) Laura M. Griffin et al. JOURNAL OF IMMUNOLOGICAL METHODS
- A general protocol for the generation of Nanobodies for structural biology
- (2014) Els Pardon et al. Nature Protocols
- Is there new hope for therapeutic matrix metalloproteinase inhibition?
- (2014) Roosmarijn E. Vandenbroucke et al. NATURE REVIEWS DRUG DISCOVERY
- Functional Antibody CDR3 Fusion Proteins with Enhanced Pharmacological Properties
- (2013) Yong Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Development of a periplasmic FRET screening method for protease inhibitory antibodies
- (2013) Dong Hyun Nam et al. BIOTECHNOLOGY AND BIOENGINEERING
- Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains
- (2013) Karl R. Schmitz et al. STRUCTURE
- A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14/MT1–MMP
- (2013) S A Shiryaev et al. Oncogenesis
- Development of a Neutralizing Antibody Specific for the Active Form of Matrix Metalloproteinase-13
- (2012) Shoichi Naito et al. BIOCHEMISTRY
- Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens
- (2012) Jiping Zhang et al. FASEB JOURNAL
- CDR-H3 Diversity Is Not Required for Antigen Recognition by Synthetic Antibodies
- (2012) Helena Persson et al. JOURNAL OF MOLECULAR BIOLOGY
- New approaches for dissecting protease functions to improve probe development and drug discovery
- (2012) Edgar Deu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Matrix metalloproteinases: protective roles in cancer
- (2011) Julie Decock et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A Reverse Binding Motif That Contributes to Specific Protease Inhibition by Antibodies
- (2011) Eric L. Schneider et al. JOURNAL OF MOLECULAR BIOLOGY
- Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential
- (2011) Netta Sela-Passwell et al. NATURE MEDICINE
- Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: Ready for prime time?
- (2010) Stanley Zucker et al. CANCER BIOLOGY & THERAPY
- Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain
- (2010) Rishabh Dev et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
- (2010) Chrisostomi Gialeli et al. FEBS Journal
- Emerging principles in protease-based drug discovery
- (2010) Marcin Drag et al. NATURE REVIEWS DRUG DISCOVERY
- Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
- (2009) Laetitia Devy et al. CANCER RESEARCH
- Matrix metalloproteinase proteomics: substrates, targets, and therapy
- (2009) Charlotte J Morrison et al. CURRENT OPINION IN CELL BIOLOGY
- Unraveling the Allosteric Mechanism of Serine Protease Inhibition by an Antibody
- (2009) Rajkumar Ganesan et al. STRUCTURE
- Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers
- (2008) Y. Liu et al. DIABETES CARE
- Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain
- (2008) Yasuhiko Kawasaki et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started